Effect of Anti-OX40 Ligand mAb on Expression of Costimulatory Molecules OX40 and OX40 Ligand on Peripheral Blood in Children with Henoch-Schonlein Purpura

WANG Xiao-peng,FENG Qi-hua,ZHANG Jian-hua,WANG Zi-cai,WU Liang-xia
2010-01-01
Abstract:Objective To investigate the expressions of costimulatory molecules OX40 and OX40 Ligand(OX40L) in children with Henoch-Schonlein purpura(HSP) and explore their possible role and significance of pathogenesis and treatment.Methods Thirty-four HSP children were regarded as research objective and 20 healthy children as healthy control group.Applying reverse transcription-polymerase chain reaction(RT-PCR) technique,using phytohemagglutinin(PHA),and anti-OX40LmAb as intervention to quantitatively analyze OX40 mRNA and OX40L mRNA expression on peripheral blood mononuclear cells(PBMC).Results Compared with healthy control group,the expressions of OX40 mRNA and OX40L mRNA both increased obviously in HSP group(Pa<0.01).After added in PHA,the expressions of OX40 mRNA and OX40L mRNA in all objective increased obviously(Pa<0.01),especially in HSP group(Pa<0.01),and then decreased obviously after added in anti-OX40LmAb(Pa<0.01).Conclusions The expressions of OX40 mRNA and OX40L mRNA in children with HSP increased abnormally,and the costimulatory molecules OX40/OX40L may play a critical role in the pathogenesis and development of HSP.Blocking the costimulatory pathway appears to be a promising approach of the therapy of HSP.
What problem does this paper attempt to address?